1. Home
  2. HTD vs CERT Comparison

HTD vs CERT Comparison

Compare HTD & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

HTD

John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

HOLD

Current Price

$25.82

Market Cap

899.3M

Sector

Finance

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.33

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTD
CERT
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
899.3M
860.9M
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
HTD
CERT
Price
$25.82
$6.33
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$11.67
AVG Volume (30 Days)
51.5K
2.5M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
N/A
$4.18
Revenue Next Year
N/A
$5.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.75
52 Week Low
$22.38
$5.19
52 Week High
$26.21
$13.88

Technical Indicators

Market Signals
Indicator
HTD
CERT
Relative Strength Index (RSI) 58.94 55.41
Support Level $24.34 $5.93
Resistance Level $26.16 $6.48
Average True Range (ATR) 0.43 0.28
MACD 0.05 0.04
Stochastic Oscillator 74.42 76.87

Price Performance

Historical Comparison
HTD
CERT

About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, communication services, materials, healthcare, real estate, consumer Staples, and short-term investments.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: